{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:12:31Z","timestamp":1788599551281,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300423769"],"award-info":[{"award-number":["252300423769"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["252102310373"],"award-info":[{"award-number":["252102310373"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bmc.2026.118776","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:14:14Z","timestamp":1786637654000},"page":"118776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phenotypic discovery of a pyrimidine derivative with dual anti-prostate cancer and cardioprotective potential via ROS modulation"],"prefix":"10.1016","volume":"142","author":[{"given":"Yaquan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa G.M.","family":"Youssif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxia","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bmc.2026.118776_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eururo.2015.12.045","article-title":"Limitations of prostate-specific antigen testing after a prostate cancer diagnosis","volume":"70","author":"Caram","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.bmc.2026.118776_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.2003.02.083","article-title":"Biology of prostate-specific antigen","volume":"21","author":"Balk","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bmc.2026.118776_bb0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/1535-7163.MCT-22-0237","article-title":"Discovery of a small-molecule inhibitor targeting the androgen receptor N-terminal domain for castration-resistant prostate cancer","volume":"22","author":"Yi","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2026.118776_bb0020","doi-asserted-by":"crossref","unstructured":"E. Capilla, R. Poyet, F.-X. Brocq, F. Pons, S. Kerebel, C. Jego, P. Laurent, G.R. Cellarier, Drugs cardiotoxicity, Presse Med (Paris, France: 1983) Vol. 44(10) (2015) 995\u20131002.","DOI":"10.1016\/j.lpm.2015.04.037"},{"key":"10.1016\/j.bmc.2026.118776_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.critrevonc.2016.04.012","article-title":"Cardiotoxicity of antiemetic drugs in oncology: an overview of the current state of the art","volume":"102","author":"Barni","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.bmc.2026.118776_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/OP.23.00494","article-title":"Cardiotoxicity of agents used in patients with breast cancer","volume":"20","author":"Zagami","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"10.1016\/j.bmc.2026.118776_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0163-7258(00)00106-6","article-title":"Opioids and cardioprotection","volume":"89","author":"Schultz","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2026.118776_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112413","article-title":"Natural and chemical compounds as protective agents against cardiac lipotoxicity","volume":"145","author":"Yarmohammadi","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.bmc.2026.118776_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tcm.2019.01.006","article-title":"Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity","volume":"30","author":"Padegimas","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"16","key":"10.1016\/j.bmc.2026.118776_bb0050","doi-asserted-by":"crossref","first-page":"14345","DOI":"10.1021\/acs.jmedchem.4c01168","article-title":"Discovery of novel Imidazo [1, 2-a] pyridine-based HDAC6 inhibitors as an anticarcinogen with a cardioprotective effect","volume":"67","author":"Yang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118776_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114526","article-title":"Discovery of 1, 3, 4-oxadiazole derivatives containing a bisamide moiety as a novel class of potential cardioprotective agents","volume":"239","author":"Yang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118776_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128654","article-title":"Novel indazole skeleton derivatives containing 1, 2, 3-triazole as potential anti-prostate cancer drugs","volume":"64","author":"Cao","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"10.1016\/j.bmc.2026.118776_bb0065","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd4366","article-title":"Phenotypic screening in cancer drug discovery\u2014past, present and future","volume":"13","author":"Moffat","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.bmc.2026.118776_bb0070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.tips.2024.06.001","article-title":"Innovating cancer drug discovery with refined phenotypic screens","volume":"45","author":"Wang","year":"2024","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.bmc.2026.118776_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103904","article-title":"Recent advances in multitarget-directed ligands via in silico drug discovery","volume":"29","author":"Maddeboina","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2026.118776_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108565","article-title":"Development of benzothiazole-grafted pyrazolo [1, 5-a] pyrimidines as new CDK2 inhibitors and anti-prostate cancer agents","volume":"161","author":"Elkotamy","year":"2025","journal-title":"Bioorg Chem"},{"issue":"4","key":"10.1016\/j.bmc.2026.118776_bb0085","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1568026622666220111143949","article-title":"Pyrimidine-fused dinitrogenous penta-heterocycles as a privileged scaffold for anti-cancer drug discovery","volume":"22","author":"Li","year":"2022","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2026.118776_bb0090","doi-asserted-by":"crossref","first-page":"914","DOI":"10.17305\/bb.2024.10735","article-title":"The cardiac toxicity of PAMAM dendrimer drug delivery systems can be attenuated with the adjunct use of cardioprotective agents","volume":"25","author":"Akhtar","year":"2024","journal-title":"Biomolecules Biomed"},{"issue":"5","key":"10.1016\/j.bmc.2026.118776_bb0095","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/jcm13051218","article-title":"Cardioprotective effects of PARP inhibitors: a re-analysis of a meta-analysis and a real-word data analysis using the FAERS database","volume":"13","author":"Han","year":"2024","journal-title":"J Clin Med"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:36:37Z","timestamp":1788597397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":19,"alternative-id":["S0968089626002324"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118776","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic discovery of a pyrimidine derivative with dual anti-prostate cancer and cardioprotective potential via ROS modulation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118776"}}